6057
Pill imprint 6057 has been identified as Glyburide and metformin HCl 1.25 mg / 250 mg.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy.
Glyburide/metformin 1.25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Glyburide and metformin HCl Images
- Imprint:
-
6057
- Strength:
- 1.25 mg / 250 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
Advertisement
More Glyburide and Metformin HCl resources
- Glyburide/Metformin (Wolters Kluwer)
- glyburide and metformin (Cerner Multum)
- glyburide and metformin (Micromedex) - Includes Dosage Information
- Glyburide and Metformin (FDA)
- Glyburide/Metformin Hydrochloride (Wolters Kluwer)
Search Again
